Product approval information is indicated for:
o Hypovolemic shock
o Hypoalbuminemia
o Prevention of central volume depletion after paracentesis due to cirrhotic ascites
o Ovarian Hyperstimulation Syndrome (OHSS)
o Adult Respiratory Distress Syndrome (ARDS)
o Burns
o Hemodialysis patients undergoin
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/B8OvY4N
No comments:
Post a Comment